Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2349)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (22)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4744)
  2. Department of Medicine (4742)
  3. Center for Pancreatic Cancer Research (2312)
  4. Surgery (1065)
  5. Survivorship Research (1013)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (219)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (147)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (320)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4744)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multi-institutional comparison of ablative 5-fraction magnetic resonance-guided online adaptive versus 15/25-fraction computed tomography-guided moderately hypofractionated offline adapted radiation therapy for locally advanced pancreatic cancer
    Journal Article

    Chuong, M. D.; O’Reilly, E. M.; Herrera, R. A.; Zinovoy, M.; Mittauer, K. E.; Rubens, M.; Kaiser, A.; Romesser, P. B.; Bassiri-Gharb, N.; Wu, A. J.; more...
    Cancers (2025)

    Fulltext@MSK | Save
  • An advanced practice provider-led telehealth intervention for oncology patients at end-of-life
    Meeting Abstract

    Lauria, T.; Qualters, K.; Kapoor-Hintzen, N.; Rosa, W.; Epstein, A.; Levine, M.; Koo, D.; Egan, B.; Puccia, S.; Gandham, A.; more...
    Journal of Pain and Symptom Management (2025)

    Fulltext@MSK | Save
  • Integration of health-related values in oncology as a primary palliative care intervention
    Meeting Abstract

    Rosa, W.; Epstein, A.; Goldberg, J.; Cohen, A.; Rosen, R.; Desai, A.; Gilliland, J.; Nelson, J.
    Journal of Pain and Symptom Management (2025)

    Fulltext@MSK | Save
  • Body mass index and somatic variants in biliary tract cancers
    Meeting Abstract

    Al Mahmasani, L.; Chou, J. F.; Capanu, M.; Srivastava, A.; Sigel, C. S.; Alsuwailem, R.; Berger, M. F.; Khalil, D. N.; Harding, J. J.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Biomarkers associated with outcomes from OPTIMIZE-1: CD40 agonist mitazalimab with mFOLFIRINOX in patients with untreated metastatic pancreatic cancer
    Meeting Abstract

    Cassier, P. A.; Van Laethem, J. L.; Borbath, I.; Macarulla, T.; Geboes, K. P.; Lambert, A.; Prenen, H.; Mitry, E.; Blanc, J. F.; Feliu, J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase 1/2 study evaluating the safety and efficacy of autologous TAC T cells in subjects with claudin 18.2(+)advanced solid tumors
    Meeting Abstract

    Sohal, D.; Iqbal, S.; Turcotte, S.; Botta, G. P.; Schlechter, B. L.; Ku, G. Y.; Hosein, P. J.; Saibil, S.; Gavriliuc, M.; Apostolopoulou, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA Phase 3 randomized clinical trial
    Journal Article

    Lau, G.; Sangro, B.; Cheng, A. L.; Kudo, M.; Kelley, R. K.; Tak, W. Y.; Gasbarrini, A.; Reig, M.; Lim, H. Y.; Tougeron, D.; more...
    Hepatology (2025)

    Fulltext@MSK | Save
  • Immune-related adverse events are associated with improved outcomes after immune checkpoint inhibitor treatment in hepatocellular carcinoma: A systematic review and meta-analysis
    Review

    Hwang, S. Y.; Rezaee-Zavareh, M. S.; Attia, A. M.; Kaymen, E. A.; Tran, N.; Abou-Alfa, G. K.; Parikh, N. D.; Singal, A. G.; Yang, J. D.
    American Journal of Gastroenterology (2025)

    Fulltext@MSK | Save
  • CT and MRI features of catenin beta 1-mutated hepatocellular carcinoma in a Western cohort
    Journal Article

    Law, W.; Zheng, J.; Kim, T. H.; Horvat, N.; Harding, J. J.; Sigel, C.; Arslan, M. E.; Wei, A.; Do, R. K.; Chernyak, V.
    Abdominal Radiology (2025)

    Fulltext@MSK | Save
  • Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline
    Guidelines

    Perez, K.; Del Rivero, J.; Kennedy, E. B.; Basu, S.; Chauhan, A.; Connolly, H. M.; Dasari, A. N.; Gangi, A.; Clarke, C. N.; Hallet, J.; more...
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save